Replies to post #70991 on Cytodyn Inc (CYDY)

[justdafactss]

Nah, I was referring to the pricing of the S-3 registration due by Thursday.

Whole new ballgame if that S-3 is priced lower than $4.50 (tee hee hee).

No wonder NP is touting a "conference" call Monday. Damage control?

Bottom line is this, no leronlimab inventory, no revenue from operations EVER IN HISTORY and no FDA approval for Lmab since the 1990's.

All of the above can be confirmed via filings and due diligence.